#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypochondroplasia Ocular myasthenia Lymphangiosarcoma Glomerulonephritis acute Fragile X syndrome Thalassaemia alpha Pouchitis Cholangiocarcinoma Crohn's disease Ewing's sarcoma Meningococcal immunisation Usher's syndrome Dermatomyositis Mastocytosis Neurotrophic keratopathy More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Life with Disease Angiosarcoma Burkitt’s lymphoma – Diagnostics Pituitary-dependent Cushing’s syndrome Lymphangiosarcoma – Basic Information Ehlers-Danlos syndrome – Trials in Disease KBG syndrome – Diagnostics Alveolar rhabdomyosarcoma – Trials in Disease Pemphigus – Diagnostics Isodicentric chromosome 15 syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anhydrous Cholestyramine Oritavancin Serine Purified Egg Phospholipids Imipenem Monohydrate Elenestinib Phosphate Chlorphenamine Maleate Esmolol Hydrochloride Cefalexin Monohydrate Magnesium Oxide, Light Festuca Rubra Pollen Zalunfiban Hydrochlorothiazide Pemetrexed Onfekafusp Alfa 534 ARLOCABTAGENE AUTOLEUCEL Ofloxacin Hydrochloride Sodium S-Lactate Solution TAGRAXOFUSP More therapies…

    Learn about Your Condition

    Oesophageal achalasia Infective uveitis Angiosarcoma metastatic Nephrotic syndrome T-cell lymphoma Cervix carcinoma recurrent Oesophageal carcinoma Meningioma Immunodeficiency congenital Polycystic ovarian syndrome Myxoid liposarcoma Primary hyperaldosteronism Systemic lupus erythematosus Ovarian epithelial cancer Double hit lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut de Cancérologie Hématologie Universitaire…

Institut de Cancérologie Hématologie Universitaire de Saint Etienne (iCHUSE)

Avenue Albert Raimond, Saint Priest En Jarez, 42270, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on GSK3858279 for Adults with Moderate to Severe Knee Osteoarthritis Pain

    Not recruiting

    2 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Gsk3858279
    France Germany Spain

  • Study on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium Czechia France Germany Hungary +3

  • Study on the Safety and Effectiveness of ABBV-668 for Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Abbv-668
    Belgium France Poland

  • Study on the Effectiveness of Co-Trimoxazole for Treating Ventilator-Associated Pneumonia in ICU Patients Compared to a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Amoxicillin
    • Amoxicillin Sodium
    • Aztreonam
    France

  • Study on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis

    Not recruiting

    3 1
    Investigated Drugs:
    • Ruxolitinib
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Secukinumab
    Bulgaria Czechia Denmark France Portugal Slovakia

  • Study on Stopping Tocilizumab for Patients with Giant Cell Arteritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Giant cell arteritis
    Investigated Drugs:
    • Tocilizumab
    France

  • Study on the Effects and Safety of Belimumab for Adults with Early Systemic Lupus Erythematosus

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Belimumab
    France Germany Greece Italy Portugal Spain

  • Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Oseltamivir
    • Paracetamol
    France

  • Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    Belgium France Germany
Previous Page
1 … 42 43 44 45 46
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!